190 related articles for article (PubMed ID: 17646170)
1. Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation.
Young JE; Gouw L; Propp S; Sopher BL; Taylor J; Lin A; Hermel E; Logvinova A; Chen SF; Chen S; Bredesen DE; Truant R; Ptacek LJ; La Spada AR; Ellerby LM
J Biol Chem; 2007 Oct; 282(41):30150-60. PubMed ID: 17646170
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunction.
Guyenet SJ; Mookerjee SS; Lin A; Custer SK; Chen SF; Sopher BL; La Spada AR; Ellerby LM
Hum Mol Genet; 2015 Jul; 24(14):3908-17. PubMed ID: 25859008
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.
Mookerjee S; Papanikolaou T; Guyenet SJ; Sampath V; Lin A; Vitelli C; DeGiacomo F; Sopher BL; Chen SF; La Spada AR; Ellerby LM
J Neurosci; 2009 Dec; 29(48):15134-44. PubMed ID: 19955365
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
Garden GA; Libby RT; Fu YH; Kinoshita Y; Huang J; Possin DE; Smith AC; Martinez RA; Fine GC; Grote SK; Ware CB; Einum DD; Morrison RS; Ptacek LJ; Sopher BL; La Spada AR
J Neurosci; 2002 Jun; 22(12):4897-905. PubMed ID: 12077187
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
[TBL] [Abstract][Full Text] [Related]
6. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
Furrer SA; Waldherr SM; Mohanachandran MS; Baughn TD; Nguyen KT; Sopher BL; Damian VA; Garden GA; La Spada AR
Hum Mol Genet; 2013 Mar; 22(5):890-903. PubMed ID: 23197655
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
8. Autophagy: polyQ toxic fragment turnover.
Duncan C; Papanikolaou T; Ellerby LM
Autophagy; 2010 Feb; 6(2):312-4. PubMed ID: 20104018
[TBL] [Abstract][Full Text] [Related]
9. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
11. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons.
Wang HL; Chou AH; Lin AC; Chen SY; Weng YH; Yeh TH
Exp Neurol; 2010 Aug; 224(2):486-94. PubMed ID: 20546728
[TBL] [Abstract][Full Text] [Related]
13. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
Hart MP; Gitler AD
J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
15. Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction.
Helmlinger D; Hardy S; Abou-Sleymane G; Eberlin A; Bowman AB; Gansmüller A; Picaud S; Zoghbi HY; Trottier Y; Tora L; Devys D
PLoS Biol; 2006 Mar; 4(3):e67. PubMed ID: 16494529
[TBL] [Abstract][Full Text] [Related]
16. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
17. Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation.
Chou AH; Chen CY; Chen SY; Chen WJ; Chen YL; Weng YS; Wang HL
Neurochem Int; 2010 Jan; 56(2):329-39. PubMed ID: 19909779
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat.
Ng H; Pulst SM; Huynh DP
Exp Neurol; 2007 Dec; 208(2):207-15. PubMed ID: 17949716
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.
Nucifora FC; Ellerby LM; Wellington CL; Wood JD; Herring WJ; Sawa A; Hayden MR; Dawson VL; Dawson TM; Ross CA
J Biol Chem; 2003 Apr; 278(15):13047-55. PubMed ID: 12464607
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
